Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2.
Zhu R, Wu Y, Huang Y, Jiang Y, Jiang Y, Zhang D, Sun H, Zhou Z, Zhou L, Weng S, Chen H, Chen X, Ning W, Zou Y, He M, Yang H, Deng W, Li Y, Chen Z, Ye X, Han J, Yin Z, Zhao H, Liu C, Que Y, Fang M, Yu H, Zhang J, Luo W, Li S, Zheng Q, Xu L, Xia N, Cheng T.
Zhu R, et al. Among authors: ning w.
Nat Microbiol. 2024 Nov;9(11):2939-2953. doi: 10.1038/s41564-024-01822-7. Epub 2024 Oct 18.
Nat Microbiol. 2024.
PMID: 39424982